Nexigen is develops drugs for indications with unmet medical need.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Cologne
State: Nordrhein-Westfalen
Zip:
Country: Germany
Nexigen GmbH develops medicines to address high unmet clinical needs in oncology. Its NexiScreen screening technology identifies disease-relevant protein-protein interactions, as well as applies to various classes of intractable drug target proteins; and detects target interacting peptides (NexiTides) where common peptide interaction screening technologies can fail.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|